Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 9892175)

1.

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE.

Cancer Res. 1999 Jan 1;59(1):8-13.

2.

The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).

Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE.

J Cell Sci. 2000 Jun;113 ( Pt 11):2011-21.

3.

Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.

Knutsen T, Rao VK, Ried T, Mickley L, Schneider E, Miyake K, Ghadimi BM, Padilla-Nash H, Pack S, Greenberger L, Cowan K, Dean M, Fojo T, Bates S.

Genes Chromosomes Cancer. 2000 Jan;27(1):110-6.

PMID:
10564593
4.

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA.

J Natl Cancer Inst. 1999 Mar 3;91(5):429-33.

5.

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE.

Clin Cancer Res. 2001 Jan;7(1):145-52.

6.

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE.

Cancer Res. 1999 Dec 1;59(23):5938-46.

7.

The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K.

Clin Cancer Res. 2002 Jan;8(1):22-8.

8.

Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone.

Lage H, Perlitz C, Abele R, Tampé R, Dietel M, Schadendorf D, Sinha P.

FEBS Lett. 2001 Aug 17;503(2-3):179-84.

9.

Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.

Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS.

Cancer Res. 2001 Jul 15;61(14):5461-7.

10.

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y.

Mol Cancer Ther. 2002 Jun;1(8):611-6.

11.

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Doyle L, Ross DD.

Oncogene. 2003 Oct 20;22(47):7340-58. Review.

PMID:
14576842
13.

Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.

Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T.

Jpn J Cancer Res. 2001 Jul;92(7):778-84.

PMID:
11473729
14.
15.

Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.

Nielsen D, Eriksen J, Maare C, Litman T, Kjaersgaard E, Plesner T, Friche E, Skovsgaard T.

Biochem Pharmacol. 2000 Aug 1;60(3):363-70.

PMID:
10856431
16.

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.

Int J Cancer. 2002 Feb 20;97(6):751-60.

PMID:
11857350
17.

Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM.

Cancer Res. 2000 Jan 1;60(1):47-50.

18.

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.

Life Sci. 2008 Sep 26;83(13-14):496-501. doi: 10.1016/j.lfs.2008.07.017. Epub 2008 Aug 3.

PMID:
18725232
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk